August 2, 2025

In 2025, Ivermectin remains a lightning rod in U.S. healthcare, emblematic of a broader clash between medical innovation, government regulation, and public opinion. Originally developed as an antiparasitic agent, Ivermectin and U.S. health policy 2025 became a polarizing symbol amid debates over drug repurposing, off-label usage, and the evolving landscape of healthcare freedom. This blog […]

Read More